Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Contura International A/S
Description97.5% water for injection and 2.5% cross-linked polyacrylamide hydrogel
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationScars / wrinkles
Indication DetailsTreat moderate to severe facial wrinkles and folds
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today